Pharmacy Quality Solutions, Inc.

pharmacyquality.com

Pharmacy Quality Solutions is the leading provider of medication use quality assessment services. We deliver the quality insights and guidance necessary to support our customers'​ efforts to optimize the quality of medication use for the populations they serve.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

news image

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More

Business Insights

XERIS BIOPHARMA ENTERS INTO AGREEMENT FOR $30 MILLION PRIVATE PLACEMENT

Xeris Biopharma Holdings | January 04, 2022

news image

Xeris Biopharma Holdings, Inc. a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today announced that on January 2, 2022, it entered into a securities purchase agreement in connection with a private placement with an affiliate of Armistice Capital, LLC for aggregate gross proceeds of approximately $30.0 million. The Private Placement is expected to close on or around January 3, 2022.
Read More

VIEWS AND ANALYSIS, PHARMA TECH

ANAQUA AND PATSNAP TEAM UP TO DELIVER AN END-TO-END PHARMA IP MANAGEMENT SOLUTION

Anaqua and PatSnap | December 08, 2022

news image

Anaqua, the leading provider of innovation and intellectual property management technology announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver an enhanced IP management solution to provide Anaqua’s pharmaceutical industry clients with a more detailed and informed view of the market and competitive landscape for key use cases. The combined Anaqua AQX® Pharma and PatSnap Synapse solutions will help AQX Pharma clients further enhance co...

Read More

PHARMA TECH

FLAGSHIP PIONEERING AND SAMSUNG ANNOUNCE COLLABORATION TO ADVANCE GROUNDBREAKING TECHNOLOGIES IN TRANSLATIONAL SCIENCE AND MEDICINE

PR Newswire | January 09, 2024

news image

Flagship Pioneering, the bioplatform innovation company, and Samsung today announced a collaboration aimed at fostering cutting-edge biopharmaceutical innovation poised to transform the world of healthcare through groundbreaking advancements in translational science and medicine. Through this collaboration, Samsung will work alongside Flagship-founded companies, leveraging Samsung's leading technologies and capabilities to accelerate first and best-in-class therapies. The ne...

Read More
news image

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More
news image

Business Insights

XERIS BIOPHARMA ENTERS INTO AGREEMENT FOR $30 MILLION PRIVATE PLACEMENT

Xeris Biopharma Holdings | January 04, 2022

Xeris Biopharma Holdings, Inc. a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today announced that on January 2, 2022, it entered into a securities purchase agreement in connection with a private placement with an affiliate of Armistice Capital, LLC for aggregate gross proceeds of approximately $30.0 million. The Private Placement is expected to close on or around January 3, 2022.
Read More

news image

VIEWS AND ANALYSIS, PHARMA TECH

ANAQUA AND PATSNAP TEAM UP TO DELIVER AN END-TO-END PHARMA IP MANAGEMENT SOLUTION

Anaqua and PatSnap | December 08, 2022

Anaqua, the leading provider of innovation and intellectual property management technology announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver an enhanced IP management solution to provide Anaqua’s pharmaceutical industry clients with a more detailed and informed view of the market and competitive landscape for key use cases. The combined Anaqua AQX® Pharma and PatSnap Synapse solutions will help AQX Pharma clients further enhance co...

Read More
news image

PHARMA TECH

FLAGSHIP PIONEERING AND SAMSUNG ANNOUNCE COLLABORATION TO ADVANCE GROUNDBREAKING TECHNOLOGIES IN TRANSLATIONAL SCIENCE AND MEDICINE

PR Newswire | January 09, 2024

Flagship Pioneering, the bioplatform innovation company, and Samsung today announced a collaboration aimed at fostering cutting-edge biopharmaceutical innovation poised to transform the world of healthcare through groundbreaking advancements in translational science and medicine. Through this collaboration, Samsung will work alongside Flagship-founded companies, leveraging Samsung's leading technologies and capabilities to accelerate first and best-in-class therapies. The ne...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us